Q-omics provides the consensus-scored OR5M2P profile across patient tissues and cancer cell-line models. OR5M2P expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in KICH. Among the 18 cancer types available for tumor–normal comparison, OR5M2P is differentially expressed in 1, with the highest sampling consensus in KIRC. Additionally, OR5M2P RNA expression shows 4,588 significant gene co-expression associations, with the highest sampling consensus in COAD. Together, these results highlight KICH, KIRC, and COAD as cancer lineages where OR5M2P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR5M2P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR5M2P survival associations across molecular data types. OR5M2P RNA expression shows survival associations in the most cancer types (10). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR5M2P RNA expression–survival associations across cancer types. High OR5M2P expression shows unfavorable associations in KICH, SKCM, LUAD, PAAD and KIRC, but favorable associations in ESCA. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KICH as the clearest survival context for OR5M2P RNA expression.
This table summarizes OR5M2P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for OR5M2P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR5M2P shows lower tumor expression in KIRC. The KIRC box plot shows higher OR5M2P RNA expression in normal versus tumor tissue (log2 FC = −0.010, t-test p = .008).
This table shows molecular features associated with OR5M2P in patient tissues and cancer cell lines. In patient samples, OR5M2P shows the broadest associations at the RNA and protein expression levels, with COAD recurring as the lineage with the largest associated feature set.
